Home › Treatments › Hematology › Cablivi

Cablivi

Hematology

Cablivi

Introduction

Cablivi (caplacizumab) is a medicine approved for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP). It is available in powder form or solution for injection, to be used in combination with plasma exchange and immunosuppressive therapy.

Safety Advice

Pregnancy: Consult Doctor

Lungs: Consult Doctor

Breastfeeding: Consult Doctor

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.